CHRONIC CORONARY SYNDROME

This study will compare two approaches for people with chronic coronary syndrome (narrowed heart arteries): getting a stent plus standard medications versus medications alone. About 2,301 participants will be randomly assigned to one group, and researchers will track major heart …

This study looks at whether icosapent ethyl, a purified fish oil medication, can reduce inflammation and improve heart structure in people with coronary artery disease. Researchers will follow 420 patients for one year, comparing those who receive standard care plus icosapent eth…

This study compares two common blood thinners, aspirin and clopidogrel, to see which one better prevents heart attacks, strokes, and related events in people with stable heart disease. About 6,740 participants from Gulf countries will take one of the two drugs for several years. …

This study tests whether glucose-lowering medications (semaglutide and possibly dapagliflozin) can reverse prediabetes and prevent complications like eye, kidney, and nerve damage in people with heart disease. About 158 participants with prediabetes and coronary artery disease wi…

This study tests a non-invasive brain training method (neurofeedback) to reduce anxiety in people with chronic coronary syndrome who are at high risk for heart events. 214 participants will receive either real or sham feedback over 4 weeks. The goal is to see if this approach low…

This early-stage trial will study how a single 16 mg dose of selatogrel, an injectable blood thinner, is absorbed and tolerated in 20 Chinese adults with chronic coronary syndrome. Participants will stay at a clinic for a few days and receive either selatogrel or a placebo. The g…

This study tests whether using a CT scan to plan a heart stent procedure (PCI) makes it faster, safer, and more effective than the usual approach. About 200 adults with coronary artery disease will either get CT-guided planning or standard care. Researchers will compare procedure…